115 avenue Lacassagne
Adocia is a clinical-stage biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins. Adocia’s insulin formulation portfolio, featuring four clinical-stage products and one preclinical product, is among the largest and most differentiated in the industry.
Founders: Gérard Soula, Olivier Soula, and Rémi Soula
CEO: Gérard Soula
CFO: Valérie Danaguezian
Please click here for Adocia job opportunities.
Please click here for clinical trial information.